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IntroductionNanostructures Formulation for Food Products: Advances in soft matter nanotechnology are increasingly being realised to offer 
smart and generic solutions in various production fields including food and agriculture industries [1]. In recent years there have been several studies reporting on nano medicinal applications of Lyotropic liquid crystalline (LLC) phases like in development of novel contrast enhancers for magnetic resonance imaging (MRI) [2,3]. Within the food and pharmaceutical research, LLC nano materials have shown potentials in the development of novel delivery systems [4-6]. These nanostructures are self-assemblies of naturally occurring surfactant-like lipid molecules which are closely related to those observed in biological membranes and 
empower the formation of efficient delivery matrices due to their impressive characteristics [6]: (i) their great interfacial area per volume ratio allow high compound loads; (ii) sustained or controlled release of compounds is supported due to their special and tuneable narrow channel networks (typically, few nano meters thick water-channels); (iii) loading of bioactive molecules with different physicochemical properties is possible, e.g., highly water-insoluble nutraceuticals can be incorporated; (iv) their effective encapsulation capabilities enhance the stability, improve bioavailability and reduce possible toxicity of administered drugs, and (v) their good bio membrane absorption properties increase the compounds transdermal penetration.Various types of LLCs form under different conditions. Stable inverse bicontinuous cubic (V2) phases spontaneously form with glycerol monooleate or phytantriol at excess water conditions at ambient temperature. Discontinuous phases such as the inverse hexagonal (H2) and the inverse micellar (L2) phase form when increasing amounts of oil are added to the LLC systems. The latter inverse structures can be imagined as isolated water droplets (e.g.L2 phase) or separated rod-like water channels (H2 phase) in a continuous oil phase, whereas in the V2 phases two intertwined, continuous water channel networks are separated by self-assembled lipid bilayers of about 3 nm thickness (Figure 
1). We note that bicontinuous cubic phases have very good temperature stability and are relatively insensitive to even extreme variations in pH and salinity, which are normally met within the gastrointestinal tract. Their aqueous dispersions were 
firstly reported in 1981 by Lindström et al. in a fat digestion study 
[7]. Later in 1996, Landh and Larsson patented the preparation of particles comprising different types of liquid crystalline phases in 
their interiors [8]. These stabilized particles with Internally Self-Assembled mesophases are sometimes referred to as ISAsomes 
[9-11] or as in this review simply termed as mesosomes.Applications of the LLC bicontinuous cubic phase containing mesosomes (cubosomes) and the inverted hexagonal phase based mesosomes (hexosomes) have received considerable attention in 
recent years [13-15]. In particular various types of stabilizers have been tested in order to formulate mesosomes with improved physico-chemical characteristics, but also to assure food or pharmacological safety aspects, Table 1. Very recently, Pickering stabilisation, in which solid nano particles are attached to the oil-water interface [16] rather than surfactant molecules, have received greater interest in the formulation of mesosomes due to the high stability and surfactant free approach offered by this 
methodology [10,17,18]. Alike bulk LLC phases, mesosomes offer loading capacities for both hydrophobic and hydrophilic bioactives, and further allow sustained release of loaded material as long as highly stable and 
appropriately sized particles are formulated. Alternatively, other studies have pointed out, how in-situ forming depots of LLC phases can be exploited for a sustained release usage [33]. Each of the underlying mesophases vary in their suitability for different administration routes or delivery of various types of bioactive 
compounds with respect to optimized encapsulation and release behavior [34]. Moreover, mesosomes have the potential to protect the incorporated molecule from oxidation and biodegradation, and structural LLC transitions can be triggered via a range of stimuli including temperature and pH. The later offers the opportunity to actively modulate the delivery system and control the compound 
 Volume 5 Issue 1 - 2016
School of Food Science and Nutrition, University of Leeds, UK
*Corresponding author: Amin Sadeghpour*, School of Food Science and Nutrition, University of Leeds, UK, Tel: +44 113 
34 32592; Email: 
Received: July 31, 2016 | Published: October 03, 2016
Mini Review 
J Nutr Health Food Eng 2016, 5(1): 00157
AbstractThe especial features and advanced characteristics of Lyotropic Liquid Crystalline (LLC) phases as potent nano materials for encapsulation and the development of novel delivery systems for nutraceuticals and other bioactive compounds are reviewed. Exemplary, a focus is set on the health benefits of flavonoids and their current restrictions in bioavailability. Accordingly, our visions for application of LLC phases in the engineering of enhanced flavonoid-based food supplements and correlated challenges to over come are highlighted.
Keywords: Lyotropic liquid crystals; ISAsomes; Mesosomes; Cubosomes; Polyphenols; Flavonoids; Smart Foods; Nano structured Functional Foods
Citation: Sadeghpour A, Rappolt M (2016) Lyotropic Liquid Crystalline Phases for the Formulation of Future Functional Foods. J Nutr Health Food Eng 5(1): 00157. DOI: 10.15406/jnhfe.2016.05.00157
Lyotropic Liquid Crystalline Phases for the Formulation of Future Functional Foods 2/5
Copyright:©2016 Sadeghpour et al.
release [34]. Further, also the release time can be tuned by varying 
the size of the carriers, however, submicron-sized particles are commonly favoured due to their high interfacial area.
Health benefits of plant based polyphenols: Plant based bioactives especially polyphenolic compounds, are biomaterials with great potentials in the development of food supplements. Flavonoids are one of the main classes of Polyphenols consisting 
of two phenyl rings and one heterocyclic group. Among flavonoids anthocyanins and catechins are two main groups having several 
reported health benefits. For example, anthocyanins from bilberry and blueberry have shown strong intracellular antioxidant activity [35] Epigallocatechin-3-gallate (EGCG), an abundant Polyphenol in green tea, has even shown to prevent tumour formation and growth. For example, colon cancer prevention activity of tea Polyphenols has been demonstrated in animal models [36]. Similarly, lemon verbena (containing Polyphenols from a popular herbal tea) has high antioxidant activity. While many phenolic compounds have shown anticancer and antibacterial activity, 
efficacy in reducing oxidative stress and other health benefits 
in vitro experiments, often their function in vivo, in particular in human, is limited due to their reduced bioavailability or 
bioactivity. Identified reasons are (i) their interactions with 
proteins or enzymes throughout the gastrointestinal (GI) tract, (ii) poor solubility in aqueous media and (iii) interactions with 
the food matrix. An overview of further plant based polyphenols 
with their health benefits and restrictions is given in (Table 2).
Table 1: Various types of stabilizers applied for the formulation of mesosomes.
Type of Stabilizer Stabilised Internal Phase
Clay mineral particles [19,20] L2, Fd3m, H2, V2*
Silica particles [17,18,21]
L2, Fd3m, H2 andV2 (only partial stabilisation)
Copolymers [22-27] L2, Fd3m, H2, V2
Proteins [26,28,29] H2, V2
Nanotubes [30] L2, Fd3m, H2, V2
Biopolymers [31,32] V2*L2 (inverse micellar phase); Fd3m (inverse micellar face-centred cubic phase); H2 (inverse hexagonal phase); V2 (inverse bicontinuous cubic phase)LLCs as the basis for novel food supplements: The applications of LLCs in encapsulation and the delivery of pharmaceuticals have been widely considered in recent years. Camptothecin [15], 
protopanaxadiol [63], dacarbazine [64] and fluorouracil [65] are the examples of nutraceuticals encapsulated into cubosomes in order to improve their delivery and hence their therapeutic behaviour. A comprehensive list of various bioactive molecules loaded into mesosomes have been reported recently in a review by Chong et al. [4] Nevertheless, the opportunities for enhancing 
the nutritional values of food by addition of flavonoids are largely 
unexploited. In particular, the interactions of flavonoids with lipid self-assemblies, formulation of polyphenol-rich mesosomes and eventually engineering of nano structured food supplements with proper taste, stability and digestibility behaviour are scarcely considered. In this respect, the challenges for highly stable and 
effective encapsulation of flavonoids through formulation of fully food-grade mesosomes which are able to protect bioactives 
throughout the different digestion stages and guarantee efficient delivery to the small intestine, still remains an essential task for the development of future functional food.
ConclusionsLLC mesosomes are potential nano materials to overcome the challenges concerning the restricted bioavailability, and 
thus, limited health benefits of current flavonoid-based food 
supplements. The flavonoids interactions with, and their release behaviour from various types of mesosomes have yet to be understood and further studies are required in order to provide 
intelligent formulations of mesosomes loaded with flavonoids as future smart food supplements.
Figure 1: Cryo-TEM observations taken for four different types of monoglyceride-based aqueous dispersions [12] and corresponding Small Angle X-ray Scattering (SAXS) patterns. Control measurements carried out on empty mesosomes demonstrate the different types of delivery systems that can be designed.
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Table 2: Reported health benefits, health risks and restrictions of some selected natural polyphenolic compounds.
Type of Polyphenol Health Benefits Health Risks Restrictions Natural Sources
Naringenin Antioxidant, anti-inflammatory and chemoprotective activity [37] Active chelator of metallic ions [37] Low absorption (6%) and rapid elimination [38] Citrus fruits
Hesperetin Antioxidant, anti-inflammatory, bloodlipid and cholesterol lowering activity 
[38]
Low absorption (4%) and rapid 
elimination [38] Citrus fruits
Genistein Anticancer activity [39] Low water solubility, low absorption (9%) [40] Pomegranate seeds [41]
Daidzein Antioxidant activity 30% bioavailability measured in urine [40] Pomegranate seeds [41]
Luteolin Anticancer, anti-hypertension and anti-inflammatory activity [42] Poor water solubility [42]low oral absorption [43] Green pepper, celery, broccoli, and parsley
Apigenin Anti-inflammatory, antioxidant and anticarcinogenic activity [44] Poor water solubility and unsatisfactory cutaneous permeability [44]Low absorption (1.2%)[45] Parsley and onion [44]
Quercetin Anticancer activity (breast, lung and prostate cancer) [46] Interactions with soy proteins [47] Limited bioavailability,reduced antioxidant activity through interactions with 
proteins [48]
Berries
Kaempferol Antioxidant, anti-inflammatory, antimicrobial, anticancer, cardioprotective, neuroprotective, 
antidiabetic activity [49]
Poor water-solubility and low bioavailability (2%) [50] Broccoli, apples
Tiliroside Antioxidant activity [51],Inhibiting of neuroinflammation [52],anti-hyperglycemiceffects [53] Inhibitory effects on carbohydrate digestion [54] Potentilla species [53]
Epigallocatechin-3-gallat (EGCG) Neuroprotective, stroke risk lowering [55] andanticancer (colon cancer) activity [36]
Complex formation thorough interaction with proteins [56,57] Low bioavailability (0.2-2%) [58] Green tea
Cyanidin Anticancer (skin and colon cancer [59]) andanti-diabetic activity [60] Low bioavailability (<1%) and unstable in-vivo [61,62] Wild mulberry/ raspberries
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